10:52 AM EST - Biovail Corp. : reported a lower fourth-quarter profit on Thursday. Canada's biggest publicly traded drug company said it earned $115.3 million, or 72 cents a share, for the period ended December 31, down from $119.7 million, or 75 cents a share, for the same time a year earlier. Analysts were expecting an average of 77 cents a share, according to Reuters Estimates. Biovail Corp.
shares T.BVF are trading up 56 cents at $24.77.
